Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Icosapent manufacturers

Filters

3 products found
The only dossier on the platform

icosapent

Capsules 1 g

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Generic equivalent to Vazkepa/Vascepa.Daily dose - 4 g
Manufacturer #30786

This company specializes in developing and supplying innovative prescription medications, particularly in the areas of cardiology and diabetes. They boast a global presence with products available in over 35 countries, including major markets in Europe, Asia, Latin America, and Africa. Their focus on combination medicines and strong R&D capabilities allow them to provide cost-effective solutions for patient health. With a decade-plus of experience, they have built a network of manufacturing sites that meet EU and other international GMP standards. While specific product patents were not found on their website, their commitment to innovation in these crucial therapeutic areas suggests a dedication to ongoing research and development.

Manufacturer usually replies in 9 days

The only dossier on the platform

icosapent + atorvastatin

Capsules 4 g + 40 mg, 4 g + 20 mg, 4 g + 10 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Form: TBD
Manufacturer #30786

This company specializes in developing and supplying innovative prescription medications, particularly in the areas of cardiology and diabetes. They boast a global presence with products available in over 35 countries, including major markets in Europe, Asia, Latin America, and Africa. Their focus on combination medicines and strong R&D capabilities allow them to provide cost-effective solutions for patient health. With a decade-plus of experience, they have built a network of manufacturing sites that meet EU and other international GMP standards. While specific product patents were not found on their website, their commitment to innovation in these crucial therapeutic areas suggests a dedication to ongoing research and development.

Manufacturer usually replies in 9 days

The only dossier on the platform

icosapent + rosuvastatin + ezetimibe

Capsules 4 g + 40 mg + 10 mg, 4 g + 20 mg + 10 mg, 4 g + 10 mg + 10 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #30786

This company specializes in developing and supplying innovative prescription medications, particularly in the areas of cardiology and diabetes. They boast a global presence with products available in over 35 countries, including major markets in Europe, Asia, Latin America, and Africa. Their focus on combination medicines and strong R&D capabilities allow them to provide cost-effective solutions for patient health. With a decade-plus of experience, they have built a network of manufacturing sites that meet EU and other international GMP standards. While specific product patents were not found on their website, their commitment to innovation in these crucial therapeutic areas suggests a dedication to ongoing research and development.

Manufacturer usually replies in 9 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.